Solventum (SOLV) POS AMProspectus update (post-effective amendment)

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the use in this Registration Statement on Form S-4 of Solventum Corporation of our report dated February 20, 2024 relating to the combined financial statements of the Health Care Business of 3M Company, which appears in this Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

/s/ PricewaterhouseCoopers LLP

Minneapolis, Minnesota

December 11, 2024